Department of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Department of Nephrology, Nara Prefecture Seiwa Medical Center, Nara, Japan.
Clin Exp Nephrol. 2024 Apr;28(4):282-292. doi: 10.1007/s10157-023-02433-y. Epub 2023 Nov 29.
Studies on kidney function and histological findings in diabetic nephropathy (DN) with low urinary protein (UP) are few. We examined the differential impact of histological changes on kidney outcomes between non-proteinuric and proteinuric DN.
Patients diagnosed with DN by renal biopsy during 1981-2014 were divided into non-proteinuric (UP ≤ 0.5 g/day) and proteinuric (UP > 0.5 g/day) DN. The Cox proportional hazard model was used to examine the association of glomerular lesions (GLs) and interstitial fibrosis and tubular atrophy (IFTA) with end-stage kidney disease (ESKD) development after adjusting for relevant confounders.
The non-proteinuric and proteinuric DN groups included 197 and 199 patients, respectively. During the 10.7-year median follow-up period, 16 and 83 patients developed ESKD in the non-proteinuric and proteinuric DN groups, respectively. In the multivariable Cox hazard model, hazard ratios (HRs) [95% confidence intervals (CIs)] of GL and IFTA for ESKD in proteinuric DN were 2.94 [1.67-5.36] and 3.82 [2.06-7.53], respectively. Meanwhile, HRs [95% CIs] of GL and IFTA in non-proteinuric DN were < 0.01 [0-2.48] and 4.98 [1.33-18.0], respectively. IFTA was consistently associated with higher incidences of ESKD regardless of proteinuria levels (P for interaction = 0.49). The prognostic impact of GLs on ESKD was significantly decreased as proteinuria levels decreased (P for interaction < 0.01).
IFTA is consistently a useful predictor of kidney prognosis in both non-proteinuric and proteinuric DN, while GLs are a significant predictor of kidney prognosis only in proteinuric DN.
患有低蛋白尿(UP)的糖尿病肾病(DN)的肾功能和组织学研究较少。我们检查了组织学变化对非蛋白尿和蛋白尿性 DN 肾脏结局的差异影响。
将 1981 年至 2014 年期间通过肾活检诊断为 DN 的患者分为非蛋白尿(UP≤0.5 g/天)和蛋白尿(UP>0.5 g/天)DN。使用 Cox 比例风险模型,在校正相关混杂因素后,检查肾小球病变(GL)和间质纤维化和肾小管萎缩(IFTA)与终末期肾病(ESKD)发展的相关性。
非蛋白尿和蛋白尿性 DN 组分别包括 197 例和 199 例患者。在 10.7 年的中位随访期间,非蛋白尿和蛋白尿性 DN 组分别有 16 例和 83 例患者发展为 ESKD。在多变量 Cox 风险模型中,蛋白尿性 DN 中 GL 和 IFTA 发生 ESKD 的风险比(HR)[95%置信区间(CI)]分别为 2.94[1.67-5.36]和 3.82[2.06-7.53]。同时,非蛋白尿性 DN 中 GL 和 IFTA 的 HR [95% CI]分别为<0.01[0-2.48]和 4.98[1.33-18.0]。无论蛋白尿水平如何,IFTA 均与更高的 ESKD 发生率相关(P 交互作用=0.49)。随着蛋白尿水平的降低,GL 对 ESKD 的预后影响显著降低(P 交互作用<0.01)。
IFTA 始终是非蛋白尿和蛋白尿性 DN 肾脏预后的有用预测指标,而 GL 仅在蛋白尿性 DN 中是肾脏预后的重要预测指标。